David S. Goldfarb, MD
David S. Goldfarb, MD
Professor of Medicine & Physiology, NYU School of Medicine
Verified email at - Homepage
Cited by
Cited by
Medical management of kidney stones: AUA guideline
MS Pearle, DS Goldfarb, DG Assimos, G Curhan, CJ Denu-Ciocca, ...
The Journal of urology 192 (2), 316-324, 2014
Medical management of kidney stones: AUA guideline
MS Pearle, DS Goldfarb, DG Assimos, G Curhan, CJ Denu-Ciocca, ...
The Journal of urology 192 (2), 316-324, 2014
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial
RL Jamison, P Hartigan, JS Kaufman, DS Goldfarb, SR Warren, ...
Jama 298 (10), 1163-1170, 2007
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis
JS Kaufman, DJ Reda, CL Fye, DS Goldfarb, WG Henderson, ...
New England Journal of Medicine 339 (9), 578-583, 1998
Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment
YR Nobel, LM Cox, FF Kirigin, NA Bokulich, S Yamanishi, I Teitler, ...
Nature communications 6 (1), 7486, 2015
A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry
DS Goldfarb, ME Fischer, Y Keich, J Goldberg
Kidney international 67 (3), 1053-1061, 2005
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD
AS Kliger, RN Foley, DS Goldfarb, SL Goldstein, K Johansen, A Singh, ...
American Journal of Kidney Diseases 62 (5), 849-859, 2013
Hereditary causes of kidney stones and chronic kidney disease
VO Edvardsson, DS Goldfarb, JC Lieske, L Beara-Lasic, F Anglani, ...
Pediatric nephrology 28, 1923-1942, 2013
Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis
JS Kaufman, TZ O’Connor, JH Zhang, RE Cronin, LD Fiore, MB Ganz, ...
Journal of the American Society of Nephrology 14 (9), 2313-2321, 2003
Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease
N Ranganathan, P Ranganathan, EA Friedman, A Joseph, B Delano, ...
Advances in therapy 27, 634-647, 2010
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness
DE Leaf, DS Goldfarb
Journal of applied physiology, 2007
Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design
JD Rimer, Z An, Z Zhu, MH Lee, DS Goldfarb, JA Wesson, MD Ward
Science 330 (6002), 337-341, 2010
Use of a probioitic to decrease enteric hyperoxaluria
JC Lieske, DS Goldfarb, C De Simone, C Regnier
Kidney international 68 (3), 1244-1249, 2005
Pathophysiology and treatment of cystinuria
J Chillarón, M Font-Llitjós, J Fort, A Zorzano, DS Goldfarb, V Nunes, ...
Nature Reviews Nephrology 6 (7), 424-434, 2010
The association of nephrolithiasis with hypertension and obesity: a review
SH Obligado, DS Goldfarb
American journal of hypertension 21 (3), 257-264, 2008
Prevalence of contraindications and prescription of pharmacologic therapies for gout
RT Keenan, WR O'Brien, KH Lee, DB Crittenden, MC Fisher, DS Goldfarb, ...
The American journal of medicine 124 (2), 155-163, 2011
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia
DE Leaf, DS Goldfarb
Kidney international 75 (1), 15-24, 2009
Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy
K Kalantar-Zadeh, M Unruh, PG Zager, CP Kovesdy, JM Bargman, J Chen, ...
American Journal of Kidney Diseases 64 (2), 181-186, 2014
Strategies for preventing calcium oxalate stones
VA Finkielstein, DS Goldfarb
Cmaj 174 (10), 1407-1409, 2006
The system can't perform the operation now. Try again later.
Articles 1–20